JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations
Clinical trial NCT04418167 · SUSPENDED
Trial details
- NCT number
- NCT04418167
- Sponsor
- JS InnoPharm, LLC
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-18
- Primary completion
- 2025-12-31
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.